422689 Sigma-AldrichKir2.1 Inhibitor, ML133 - CAS 185669-79-8 - Calbiochem
The Kir2.1 Inhibitor, ML133, also referenced under CAS 185669-79-8, controls the biological activity of Kir2.1. This small molecule/inhibitor is primarily used for Cancer applications.
More>> The Kir2.1 Inhibitor, ML133, also referenced under CAS 185669-79-8, controls the biological activity of Kir2.1. This small molecule/inhibitor is primarily used for Cancer applications. Less<<Sinónimos: Inward rectifier potassium channel blocker, ML133
Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
CAS # | Empirical Formula |
---|---|
185669-79-8 | C₁₉H₁₉NO |
Precios y disponibilidad
Número de referencia | Disponiblidad | Embalaje | Cant./Env. | Precio | Cantidad | |
---|---|---|---|---|---|---|
422689-5MG |
|
Frasco de vidrio | 5 mg |
|
— |
References | |
---|---|
References | Lindsley, C.W., et al. 2011. ACS Chem. Biol. 6, 845. |
Product Information | |
---|---|
CAS number | 185669-79-8 |
Form | White solid |
Hill Formula | C₁₉H₁₉NO |
Chemical formula | C₁₉H₁₉NO |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Purity | ≥95% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
422689-5MG | 04055977187229 |
Documentation
Kir2.1 Inhibitor, ML133 - CAS 185669-79-8 - Calbiochem Ficha datos de seguridad (MSDS)
Título |
---|
Kir2.1 Inhibitor, ML133 - CAS 185669-79-8 - Calbiochem Certificados de análisis
Cargo | Número de lote |
---|---|
422689 |
Referencias bibliográficas
Visión general referencias |
---|
Lindsley, C.W., et al. 2011. ACS Chem. Biol. 6, 845. |